Chattopadhyay, Mitali <br/><br/>
Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.  [electronic resource] 

 -  Biochemical pharmacology  Mar 2012 
 - 723-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2011.12.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Apoptosis--drug effects<br/>Aspirin--analogs & derivatives<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Female<br/>Humans<br/>Hydrogen Sulfide--chemistry<br/>Mice<br/>NF-kappa B--antagonists & inhibitors<br/>Reactive Oxygen Species--metabolism<br/>Receptors, Estrogen--genetics<br/>Signal Transduction--drug effects<br/>Thiones--chemistry<br/>Thioredoxin-Disulfide Reductase--metabolism<br/>Xenograft Model Antitumor Assays